Results 41 to 50 of about 1,352 (181)

JSLE and healthy control immune phenotype

open access: yes, 2021
Data on juvenile-onset systemic lupus erythematosus (JSLE) patients and healthy control immune phenotype (immune frequency) using flow ...
Robinson, G (via Mendeley Data)
core   +1 more source

Vasculitis in Juvenile-Onset Systemic Lupus Erythematosus

open access: yesFrontiers in Pediatrics, 2019
Juvenile-onset systemic lupus erythematosus (JSLE) is a rare, heterogeneous multisystem autoimmune disease that can affect any organ, and present with diverse clinical and serological manifestations. Vasculitis can be a feature of JSLE.
Eve M. D. Smith   +4 more
doaj   +1 more source

AB0983 LIPID METABOLISM AND DISEASE ACTIVITY IN JSLE PATIENTS [PDF]

open access: yesAnnals of the Rheumatic Diseases, 2020
Background: Systemic lupus erythematosus (SLE) is an autoimmune systemic disease associated with premature atherosclerosis. Risk factors include dyslipoproteinemia, inflammation, oxidized low-density lipoprotein (LDL), hyperhomocysteinemia and antiphospholipid antibodies.
S. Ganhão   +4 more
openaire   +1 more source

Aquaporin-4 IgG antibodies: predictors of positivity and their relationship with neuropsychiatric disorders and white matter lesions in Juvenile systemic lupus erythematosus

open access: yesPediatric Rheumatology Online Journal, 2023
Background This study aimed to describe the prevalence of the various clinical features and severity of juvenile systemic lupus erythematosus (jSLE) and to assess predictors of AQP4-Ab positivity in jSLE. In addition, we assessed the relationship of AQP4-
Yasmeen Shaaban   +4 more
doaj   +1 more source

Ovarian dysfunction in adolescent girls with autoimmune rheumatic diseases

open access: yesPediatric Rheumatology Online Journal, 2023
Objective To explore the different menstrual and pubertal abnormalities in adolescent females with systemic autoimmune rheumatic diseases (ARD). Methods The study included adolescent girls aged 13–18 years with juvenile idiopathic arthritis (JIA ...
Mohamed Taman   +3 more
doaj   +1 more source

Lymphocyte subset distribution during longitudinal follow-up in JSLE patients.

open access: yes, 2022
(A) Percentages of lymphocyte subsets in 34 JSLE patients during active disease and follow-up until inactive disease. (B) Disease activity measured by SLEDAI-2K during active disease and follow-up until inactive disease in 34 JSLE patients.
Butsabong Lerkvaleekul (12055191)   +5 more
core   +1 more source

P24 Correlation between serum autoantibodies and clinical manifestations in jSLE [PDF]

open access: yesPoster presentations, 2020
Background Systemic Lupus Erythematosus (SLE) has a large clinical spectrum, ranging from mild to severe disease. Some studies have proven correlations between specific autoantibodies and particular clinical manifestations. The aim is to assess if there is any correlation between autoantibodies and clinical manifestations in our sample.
Sara Ganhão   +3 more
openaire   +1 more source

IgA vasculitis (Henoch – Schönlein Purpura) as the first manifestation of juvenile Systemic Lupus Erythematosus: Case-control study and systematic review

open access: yesBMC Pediatrics, 2019
Background We have recognized 15 children with jSLE and the antecedent of IgA vasculitis (HSP). This association is not broadly present in the literature.
Chiharu Murata   +7 more
doaj   +1 more source

Atopy in children with juvenile systemic lupus erythematosus is associated with severe disease. [PDF]

open access: yesPLoS ONE, 2017
The influence of co-existing atopy on the prognosis of juvenile systemic lupus erythematosus (JSLE) was assessed in this study. Patients diagnosed with JSLE between October 2005 and April 2016 were enrolled in a prospective study and followed up for 2 ...
Ruru Guo   +4 more
doaj   +1 more source

What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012?

open access: yesFrontiers in Pediatrics, 2022
IntroductionJuvenile-onset systemic lupus erythematous (JSLE) is a rare multisystem autoimmune disorder. In 2012, the Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) initiative developed recommendations for the diagnosis ...
Kathy L. Gallagher   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy